207 related articles for article (PubMed ID: 24618744)
1. Circular Dichroism studies on the interactions of antimicrobial peptides with bacterial cells.
Avitabile C; D'Andrea LD; Romanelli A
Sci Rep; 2014 Mar; 4():4293. PubMed ID: 24618744
[TBL] [Abstract][Full Text] [Related]
2. Studying the Interaction of Magainin 2 and Cecropin A with E. coli Bacterial Cells Using Circular Dichroism.
Avitabile C; D'Andrea LD; Romanelli A
Methods Mol Biol; 2017; 1548():247-253. PubMed ID: 28013509
[TBL] [Abstract][Full Text] [Related]
3. Specific interactions of the antimicrobial peptide cyclic beta-sheet tachyplesin I with lipopolysaccharides.
Hirakura Y; Kobayashi S; Matsuzaki K
Biochim Biophys Acta; 2002 May; 1562(1-2):32-6. PubMed ID: 11988219
[TBL] [Abstract][Full Text] [Related]
4. Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria.
Matsuzaki K; Sugishita K; Miyajima K
FEBS Lett; 1999 Apr; 449(2-3):221-4. PubMed ID: 10338136
[TBL] [Abstract][Full Text] [Related]
5. Cecropin A - magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect.
Shin SY; Kang JH; Lee MK; Kim SY; Kim Y; Hahm KS
Biochem Mol Biol Int; 1998 May; 44(6):1119-26. PubMed ID: 9623765
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.
Fox MA; Thwaite JE; Ulaeto DO; Atkins TP; Atkins HS
Peptides; 2012 Feb; 33(2):197-205. PubMed ID: 22289499
[TBL] [Abstract][Full Text] [Related]
7. Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.
Strandberg E; Zerweck J; Horn D; Pritz G; Berditsch M; Bürck J; Wadhwani P; Ulrich AS
J Pept Sci; 2015 May; 21(5):436-45. PubMed ID: 25898805
[TBL] [Abstract][Full Text] [Related]
8. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.
Tachi T; Epand RF; Epand RM; Matsuzaki K
Biochemistry; 2002 Aug; 41(34):10723-31. PubMed ID: 12186559
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
Lee JK; Seo CH; Luchian T; Park Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969
[TBL] [Abstract][Full Text] [Related]
10. Development of Amphipathic Antimicrobial Peptide Foldamers Based on Magainin 2 Sequence.
Goto C; Hirano M; Hayashi K; Kikuchi Y; Hara-Kudo Y; Misawa T; Demizu Y
ChemMedChem; 2019 Nov; 14(22):1911-1916. PubMed ID: 31667994
[TBL] [Abstract][Full Text] [Related]
11. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.
Kobayashi S; Takeshima K; Park CB; Kim SC; Matsuzaki K
Biochemistry; 2000 Jul; 39(29):8648-54. PubMed ID: 10913273
[TBL] [Abstract][Full Text] [Related]
12. Highly synergistic antimicrobial activity of magainin 2 and PGLa peptides is rooted in the formation of supramolecular complexes with lipids.
Aisenbrey C; Amaro M; Pospíšil P; Hof M; Bechinger B
Sci Rep; 2020 Jul; 10(1):11652. PubMed ID: 32669585
[TBL] [Abstract][Full Text] [Related]
13. Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity.
Shin A; Lee E; Jeon D; Park YG; Bang JK; Park YS; Shin SY; Kim Y
Biochemistry; 2015 Jun; 54(25):3921-31. PubMed ID: 26053120
[TBL] [Abstract][Full Text] [Related]
14. Synergy on Surfaces: Anti-Biofouling Interfaces Using Surface-Attached Antimicrobial Peptides PGLa and Magainin-2.
Shtreimer Kandiyote N; Mohanraj G; Mao C; Kasher R; Arnusch CJ
Langmuir; 2018 Sep; 34(37):11147-11155. PubMed ID: 30122046
[TBL] [Abstract][Full Text] [Related]
15. Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin.
Ramamoorthy A; Thennarasu S; Lee DK; Tan A; Maloy L
Biophys J; 2006 Jul; 91(1):206-16. PubMed ID: 16603496
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin.
Jacob L; Zasloff M
Ciba Found Symp; 1994; 186():197-216; discussion 216-23. PubMed ID: 7768152
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Antimicrobial Peptide Magainin 2 and Nonlipid Components in the Bacterial Outer Envelope.
Montero Vega S; Booth V; Rowley CN
J Phys Chem B; 2022 Jul; 126(29):5473-5480. PubMed ID: 35829704
[TBL] [Abstract][Full Text] [Related]
18. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Kang JH; Hahm KS
J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
[TBL] [Abstract][Full Text] [Related]
19. Interactions between magainin 2 and Salmonella typhimurium outer membranes: effect of lipopolysaccharide structure.
Rana FR; Macias EA; Sultany CM; Modzrakowski MC; Blazyk J
Biochemistry; 1991 Jun; 30(24):5858-66. PubMed ID: 2043628
[TBL] [Abstract][Full Text] [Related]
20. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria.
Matsuzaki K; Sugishita K; Harada M; Fujii N; Miyajima K
Biochim Biophys Acta; 1997 Jul; 1327(1):119-30. PubMed ID: 9247173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
